title: HyperCKemia induced by levetiracetam.
authors.affiliation: Centre hospitalier Lens, service pharmacie, 62300 Lens, France.
authors.forename: Mélanie
authors.initials: M
authors.lastname: Ramon
authors.affiliation: Centre hospitalier Lens, unité de surveillance continue, 62300 Lens, France.
authors.forename: Emilie
authors.initials: E
authors.lastname: Tourteau
authors.affiliation: Centre hospitalier Lens, service pharmacie, 62300 Lens, France.
authors.forename: Noémie
authors.initials: N
authors.lastname: Lemaire
authors.affiliation: CHU de Lille, centre régional de pharmacovigilance du Nord-Pas-de-Calais, 59000 Lille, France; Université Lille 2, U1171, 59000 Lille, France; Inserm, U1171, 59000 Lille, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Gautier
authors.affiliation: CHU de Lille, centre régional de pharmacovigilance du Nord-Pas-de-Calais, 59000 Lille, France; Université Lille 2, U1171, 59000 Lille, France; Inserm, U1171, 59000 Lille, France. Electronic address: johana.bene@chru-lille.fr.
authors.forename: Johana
authors.initials: J
authors.lastname: Béné
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood*; D006801:Humans; D000077287:Levetiracetam; D008297:Male; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000927:Anticonvulsants; D000077287:Levetiracetam; D003402:Creatine Kinase; D010889:Piracetam